Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mallinckrodt Public Limited Company (MNK)

21.49   0.97 (4.73%) 02-22 16:00
Open: 21.03 Pre. Close: 20.52
High: 21.6 Low: 20.44
Volume: 1,543,169 Market Cap: 1790M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 21.611 - 21.717 21.717 - 21.825
Low: 20.197 - 20.304 20.304 - 20.413
Close: 21.312 - 21.487 21.487 - 21.666

Technical analysis

as of: 2019-02-22 4:44:58 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 27.00     One year: 31.54
Support: Support1: 20.90    Support2: 19.52
Resistance: Resistance1: 23.12    Resistance2: 27.00
Pivot: 21.57
Moving Average: MA(5): 21.39     MA(20): 21.58
MA(100): 23.38     MA(250): 21.91
MACD: MACD(12,26): 0.24     Signal(9): 0.35
Stochastic oscillator: %K(14,3): 33.66     %D(3): 41.49
RSI: RSI(14): 53.00
52-week: High: 36.65  Low: 11.65  Change(%): 33.0
Average Vol(K): 3-Month: 200453  10-Days: 107233

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MNK has closed above bottom band by 46.7%. Bollinger Bands are 63.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to MNK's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 22 Feb 2019 16:29:29 Z featured highlights include: Mallinckrodt, Dell, American Axle, Daqo and General Motors

Fri, 22 Feb 2019 16:27:08 Z
What's in the Cards for Perrigo (PRGO) This Earnings Season?

Thu, 21 Feb 2019 15:17:17 Z
Another Round of Slight Gains Amid Choppy Session

Wed, 20 Feb 2019 22:07:01 Z
Mylan (MYL) to Report Q4 Earnings: What's in the Offing?

Wed, 20 Feb 2019 06:06:52 Z
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 83.31
Shares Float (M) 82.19
% Held by Insiders
% Held by Institutions 156.70
Shares Short (K) 24330
Shares Short P. Month (K)

Stock Financials

EPS 7.200
EPS Est. Current Year 7.370
EPS Est. Next Year 8.020
EPS Est. Next Quarter 2.030
Forward EPS 6.891
Book Value (p.s.) 0.280
PEG Ratio 0.33
Profit Margin 6.04
Operating Margin 18.75
Return on Assets (ttm) 11.7
Return on Equity (ttm) 29.5
Qtrly Rev. Growth 6.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 78.60
Operating Cash Flow (M) 759.90
Levered Free Cash Flow (M) 407.86

Stock Valuations

P/E 2.98
P/E Growth Ratio 0.05
P/BV 76.75
P/S 46708372.00
P/CF 2.36

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2012-12-12
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.